Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis

Association between Sarcopenic Obesity and Nonalcoholic Fatty Liver Disease and Fibrosis detected by Fibroscan

(2021) Karn Wijarnpreecha et al.   Journal of Gastrointestinal and Liver Diseases

Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus

(2020) Min Je Sung et al.   Gut and Liver

Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences

(2020) So-hyeon Hong et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Relationship between low skeletal muscle mass, sarcopenic obesity and left ventricular diastolic dysfunction in Korean adults

(2020) Jee Hee Yoo et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

(2019) Peter J. Eddowes et al.   GASTROENTEROLOGY

Diagnostic Criteria and Clinical Outcomes in Sarcopenia Research: A Literature Review

(2018) Alex Han et al.   Journal of Clinical Medicine

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function

(2017) Gijs H. Goossens   Obesity Facts

Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study

(2017) Yi-Hao Yen et al.   PLoS One

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Recent Advances in Sarcopenia Research in Asia: 2016 Update From the Asian Working Group for Sarcopenia

(2016) Liang-Kung Chen et al.   Journal of the American Medical Directors Association

Transient elastography (FibroScan®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

(2016) Ivana Mikolasevic et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance

(2016) Kuen Cheh Yang et al.   Scientific Reports

Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis

(2015) Mi Na Kim et al.   HEPATOLOGY

The Implications of Sarcopenia and Sarcopenic Obesity on Cardiometabolic Disease

(2015) Tae Nyun Kim et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis: a prospective study

(2015)   Journal of Gastrointestinal and Liver Diseases

How Inflammation Impinges on NAFLD: A Role for Kupffer Cells

(2015) Nádia Duarte et al.   Biomed Research International

Hepatic inflammation and progressive liver fibrosis in chronic liver disease

(2014) Albert J Czaja   WORLD JOURNAL OF GASTROENTEROLOGY

Presence of sarcopenia (muscle wasting) in patients with nonalcoholic steatohepatitis

(2013) Danny Issa et al.   HEPATOLOGY

Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study

(2012) Tae Nyun Kim et al.   CLINICAL ENDOCRINOLOGY

Sarcopenic obesity: A Critical appraisal of the current evidence

(2012) C.M.M. Prado et al.   CLINICAL NUTRITION

Associação entre sarcopenia, obesidade sarcopênica e força muscular com variáveis relacionadas de qualidade de vida em idosas

(2012) Luiz S. Silva Neto et al.   Brazilian Journal of Physical Therapy

Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia

(2011) Roger A. Fielding et al.   Journal of the American Medical Directors Association

Sarcopenic Obesity: Prevalence and Association With Metabolic Syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA)

(2010) S. Lim et al.   DIABETES CARE

Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan)

(2010) Kyu Sik Jung et al.   HEPATOLOGY

Controlled Attenuation Parameter (CAP): A Novel VCTE™ Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes

(2010) Magali Sasso et al.   ULTRASOUND IN MEDICINE AND BIOLOGY